Healthcare and life sciences: navigating a hard Brexit scenario
In this session, we will discuss the challenges that still need to be addressed by the healthcare and life science industry as a hard Brexit looks more likely.
We are very honoured to welcome Sandra Humphrey, Senior Legal Counsel at GlaxoSmithKline plc, who will give us a glimpse of GSK’s Brexit journey. Our international team of experts will then explore regulatory, IP, competition, tax and corporate issues to help you navigate these uncertain times.
.jpg?crop=300,495&format=webply&auto=webp)
.jpg?crop=300,495&format=webply&auto=webp)
.jpg?crop=300,495&format=webply&auto=webp)
_11zon_11zon.jpg?crop=300,495&format=webply&auto=webp)
_11zon.jpg?crop=300,495&format=webply&auto=webp)